title: Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.
authors.affiliation: Urology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
authors.forename: David S
authors.initials: DS
authors.lastname: Yee
authors.forename: Shahrokh F
authors.initials: SF
authors.lastname: Shariat
authors.forename: William T
authors.initials: WT
authors.lastname: Lowrance
authors.forename: Joseph R
authors.initials: JR
authors.lastname: Sterbis
authors.forename: Kinjal C
authors.initials: KC
authors.lastname: Vora
authors.forename: Bernard H
authors.initials: BH
authors.lastname: Bochner
authors.forename: S Machele
authors.initials: SM
authors.lastname: Donat
authors.forename: Harry W
authors.initials: HW
authors.lastname: Herr
authors.forename: Guido
authors.initials: G
authors.lastname: Dalbagni
authors.forename: Jaspreet S
authors.initials: JS
authors.lastname: Sandhu
mesh_terms: D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use; D001918:Brachytherapy; D016009:Chi-Square Distribution; D003131:Combined Modality Therapy; D015653:Cystectomy; D018450:Disease Progression; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000532:radiotherapy* / Q000628:therapy; D018426:SEER Program; D015996:Survival Rate; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D001749:Urinary Bladder Neoplasms / Q000453:epidemiology / Q000628:therapy*
chemical_list: D000726:Androgen Antagonists